US-based Spineology has received US Food and Drug Administration (FDA) approval to use allograft bone with its Rampart Interbody fusion devices.

The Rampart Interbody fusion devices incorporate large graft windows to help healing, and a recently enhanced instrumentation system.

Further, the devices are available sterile packed, thereby removing the requirement for continual reprocessing, which cuts down costs for customers.

"In addition to reducing patient morbidity and enhancing surgical efficiency we expect this approval will provide Spineology with an excellent platform for delivery of our new Incite Cortical Fibers."

Spineology chief executive officer John Booth said: “This approval and our recent partnership expansion with Musculoskeletal Transplant Foundation (MTF) provides us the ability to pair MTF allografts with the Rampart family of interbody devices.

In addition to reducing patient morbidity and enhancing surgical efficiency we expect this approval will provide Spineology with an excellent platform for delivery of our new Incite Cortical Fibers.”

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Incite Cortical Fibers are a versatile bone grafting solution.

The fibers provide an osteoconductive and inductive matrix, handling properties, in-situ expansion and placement options through a variety of delivery methods.

Spineology offers anatomy conserving spinal technologies for surgeons and patients.